Literature DB >> 274993

The Ommaya reservoir: newly recognized complications and recommendations for insertion and use.

W A Bleyer, P A Pizzo, A M Spence, W D Platt, D R Benjamin, C J Kolins, D G Poplack.   

Abstract

Two of 27 patients treated with intraventricular chemotherapy via an Ommaya reservoir developed unusual life-threatening complications attributable to the reservoir. In one patient treated for meningeal Burkitt's lymphoma, the cause of death was a large mass of tumor cells growing around the cannula. Also the tip of the cannula was found in the contralateral cerebral peduncle. In the other patient, the tip of the cannula apparently perforated the ventricular wall postoperatively and migrated into the contralateral thalamus. In both cases evidence for methotrexate-associated leukoencephalopathy was present at autopsy. Based on the experience with these two patients, we offer specific recommendations for reservoir insertion and use.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 274993     DOI: 10.1002/1097-0142(197806)41:6<2431::aid-cncr2820410650>3.0.co;2-3

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

1.  Neurological and behavioral sequelae following different approaches to craniopharyngioma. Long-term follow-up review and therapeutic guidelines.

Authors:  M Colangelo; A Ambrosio; C Ambrosio
Journal:  Childs Nerv Syst       Date:  1990-11       Impact factor: 1.475

Review 2.  The Use of Ommaya Reservoirs to Deliver Central Nervous System-Directed Chemotherapy in Childhood Acute Lymphoblastic Leukaemia.

Authors:  Ruairi Wilson; Caroline Osborne; Christina Halsey
Journal:  Paediatr Drugs       Date:  2018-08       Impact factor: 3.022

Review 3.  Reservoir systems for intraventricular chemotherapy.

Authors:  U Berweiler; A Krone; J C Tonn
Journal:  J Neurooncol       Date:  1998 Jun-Jul       Impact factor: 4.130

4.  Safety and pharmacokinetic analysis of methotrexate administered directly into the fourth ventricle in a piglet model.

Authors:  David I Sandberg; Juan Solano; Carol K Petito; Abdul Mian; Caihong Mou; Tulay Koru-Sengul; Manuel Gonzalez-Brito; Kyle R Padgett; Ali Luqman; Juan Carlos Buitrago; Farid Alam; Jerome R Wilkerson; Kenneth M Crandall; John W Kuluz
Journal:  J Neurooncol       Date:  2010-05-04       Impact factor: 4.130

Review 5.  Transient focal leukoencephalopathy following intraventricular methotrexate and cytarabine. A complication of the Ommaya reservoir: case report and review of the literature.

Authors:  V Colamaria; R Caraballo; C Borgna-Pignatti; P Marradi; R Balter; C Mazza; C Procacci; B Dalla Bernardina
Journal:  Childs Nerv Syst       Date:  1990-06       Impact factor: 1.475

6.  Complications related to the use of an intraventricular access device for the treatment of leptomeningeal metastases from solid tumor: a single centre experience in 112 patients.

Authors:  Fahed Zairi; Emilie Le Rhun; Nicolas Bertrand; Thomas Boulanger; Sophie Taillibert; Rabih Aboukais; Richard Assaker; Marc C Chamberlain
Journal:  J Neurooncol       Date:  2015-06-13       Impact factor: 4.130

Review 7.  Neoplastic meningitis: diagnosis and treatment considerations.

Authors:  S M Blaney; D G Poplack
Journal:  Med Oncol       Date:  2000-08       Impact factor: 3.064

8.  Methotrexate induced brain necrosis and severe leukoencephalopathy due to disconnection of an Ommaya device.

Authors:  R de Waal; P R Algra; J J Heimans; J G Wolbers; P Scheltens
Journal:  J Neurooncol       Date:  1993-03       Impact factor: 4.130

Review 9.  Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.

Authors:  Phatsapong Yingchoncharoen; Danuta S Kalinowski; Des R Richardson
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

10.  Pharmacokinetic analysis of etoposide distribution after administration directly into the fourth ventricle in a piglet model.

Authors:  David I Sandberg; Kenneth M Crandall; Tulay Koru-Sengul; Kyle R Padgett; John Landrum; Darwin Babino; Carol K Petito; Juan Solano; Manuel Gonzalez-Brito; John W Kuluz
Journal:  J Neurooncol       Date:  2009-08-18       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.